To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
BioTek Awarded Patent for Hybrid Technology™
BioTek has been awarded US patent 8,218,141 covering the combination of two alternate paths for light within the same analytical instrument.
Known as Hybrid Technology™, the patented functionality is available in BioTek's Synergy™ NEO HTS Multi-Mode Microplate Reader and in the Synergy H4 and H1 Hybrid Multi-Mode Microplate Readers.
Using Hybrid Technology, light can be directed to and from the microplate samples through a filter-based optical system or through a monochromator-based optical system for wavelength selection.
This two-optical-path system provides optimal performance and flexibility for a wide range of applications in fluorescence microplate assays.
BioTek's Synergy readers are modular platforms that can include Fluorescence Intensity, UV-Vis Absorbance, Luminescence, TRF, TR-FRET and FP detection modes.
